Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Inhibition of CDK1 by RO-3306 Exhibits Anti-Tumorigenic Effects in Ovarian Cancer Cells and a Transgenic Mouse Model of Ovarian Cancer.
Journal: International journal of molecular sciences
Published: June 26, 2023
Anti-Tumor and Anti-Invasive Effects of ONC201 on Ovarian Cancer Cells and a Transgenic Mouse Model of Serous Ovarian Cancer.
Journal: Frontiers in oncology
Published: October 04, 2021
Docosahexaenoic acid (DHA), an omega-3 fatty acid, inhibits tumor growth and metastatic potential of ovarian cancer.
Journal: American journal of cancer research
Published: September 22, 2020
Targeting dopamine receptor D2 as a novel therapeutic strategy in endometrial cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: September 21, 2020
Is hormonal therapy after risk-reducing salpingo-oophorectomy associated with an increased risk of malignancy in pathogenic variant carriers?
Journal: Gynecologic oncology
Published: November 27, 2019
Sarcopenia as a predictor of survival and chemotoxicity in patients with epithelial ovarian cancer receiving platinum and taxane-based chemotherapy.
Journal: Gynecologic oncology
Published: November 04, 2019
Post-radiation angiosarcoma of the uterine cervix.
Journal: Gynecologic oncology reports
Published: March 25, 2019
ONC201 demonstrates anti-tumorigenic and anti-metastatic activity in uterine serous carcinoma in vitro.
Journal: American journal of cancer research
Published: June 25, 2018
Impact of Trainee Involvement in Cervical Excision Procedures: Does Trainee Involvement Impact Quality?
Journal: Journal of lower genital tract disease
Published: December 23, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026